Muscle Tissue Articles & Analysis
11 news found
It is specifically designed to preferentially block CB1 receptors in peripheral tissues such as the kidneys, gastro-intestinal tract, liver, pancreas, adipose tissues, muscles, lungs and other organs. ...
It is specifically designed to preferentially block CB1 receptors in peripheral tissues such as the kidneys, gastro-intestinal tract, liver, pancreas, adipose tissues, muscles, lungs and other organs. ...
It is specifically designed to preferentially interact with peripheral CB1 receptors located in the kidneys, gastro-intestinal tract, liver, pancreas, adipose tissues, muscles, lungs and other organs, thus aiming at a safe and effective therapeutic approach without the known liabilities of centrally-acting CB1 blockers. ...
AVR-RD-03, AVROBIO’s gene therapy for Pompe disease, includes a proprietary Glycosylation-Independent Lysosomal Targeting (GILT)-tag which consists of a short peptide sequence linked to the therapeutic protein and is designed to enhance uptake in targeted tissues. “Pompe disease is a progressive, life-limiting neuromuscular disorder caused by the accumulation of ...
Clinically, frailty manifests as a combination of symptoms that includes loss of muscle and decreased strength, slowed walking, low activity and energy levels, poor endurance, nutritional deficiencies, weight loss and fatigue. ...
The investigational gene therapy will be administered directly to the muscle tissue of the heart by an experienced cardiac surgeon. The EXACT Trial was initiated in 2020 and is ongoing at top cardiovascular research sites across the United States. About Chronic Refractory Angina Chronic angina pectoris occurs when the heart muscle does not ...
Computed tomography(CT)-guided radiofrequency ablation (RFA), the most commonly used osteoid osteoma treatment, requires drilling through muscle and soft tissue into bone, and also exposes the patient to radiation from the imaging necessary to guide the probe that is inserted to heat and destroy tumor tissue. Sonalleve® is an innovative ...
This two-year grant provides $996,609 in funding to continue advancing Fibralign’s development of a novel treatment of volumetric muscle loss. Project Title: Aligned Nanofibrillar Scaffold Activated with HGF-mmRNA in Combination with Minced Muscle Graft for Treating Volumetric Muscle Loss (VML) Injury This new project builds on ...
Fascia is the head-to-toe connective tissue that runs throughout the entire body. The fascia encompasses all the body’s internal structures, connecting everything together, even penetrating the muscles, organs and fatty tissues, and connecting bones to muscles and organs to each other. ...
The Centers for Disease Control and Prevention (CDC) states, “Severe, sometimes life-threatening, GAS disease may occur when bacteria get into parts of the body where bacteria usually are not found, such as the blood, muscle, or the lungs. These infections are termed "invasive GAS disease." ...
Necrotizing fasciitis, also known as "the flesh-eating bacteria", is a rapidly progressing disease which destroys muscles, fat and skin tissue. Flesh eating bacteria releases toxins that destroy the surrounding tissue. ...